弹性蛋白
心肌梗塞
细胞外基质
医学
心脏病学
结扎
血管生成
体内
间质细胞
缺血性心肌病
纤维化
肌成纤维细胞
生物医学工程
化学
心力衰竭
病理
癌症研究
外科
射血分数
生物
生物化学
生物技术
作者
Paolo Contessotto,Doriana Orbanić,Mark Da Costa,Chunsheng Jin,Peter Owens,Sandrine Chantepie,Clizia Chinello,John Newell,Fulvio Magni,Dulcé Papy-Garcia,Niclas G. Karlsson,Michelle Kilcoyne,Peter Dockery,José Carlos Rodríguez‐Cabello,Abhay Pandit
标识
DOI:10.1126/scitranslmed.aaz5380
摘要
Ischemic heart disease is a leading cause of mortality due to irreversible damage to cardiac muscle. Inspired by the post-ischemic microenvironment, we devised an extracellular matrix (ECM)-mimicking hydrogel using catalyst-free click chemistry covalent bonding between two elastin-like recombinamers (ELRs). The resulting customized hydrogel included functional domains for cell adhesion and protease cleavage sites, sensitive to cleavage by matrix metalloproteases overexpressed after myocardial infarction (MI). The scaffold permitted stromal cell invasion and endothelial cell sprouting in vitro. The incidence of non-transmural infarcts has increased clinically over the past decade, and there is currently no treatment preventing further functional deterioration in the infarcted areas. Here, we have developed a clinically relevant ovine model of non-transmural infarcts induced by multiple suture ligations. Intramyocardial injections of the degradable ELRs-hydrogel led to complete functional recovery of ejection fraction 21 days after the intervention. We observed less fibrosis and more angiogenesis in the ELRs-hydrogel-treated ischemic core region compared to the untreated animals, as validated by the expression, proteomic, glycomic, and histological analyses. These findings were accompanied by enhanced preservation of GATA4+ cardiomyocytes in the border zone of the infarct. We propose that our customized ECM favors cardiomyocyte preservation in the border zone by modulating the ischemic core and a marked functional recovery. The functional benefits obtained by the timely injection of the ELRs-hydrogel in a clinically relevant MI model support the potential utility of this treatment for further clinical translation.
科研通智能强力驱动
Strongly Powered by AbleSci AI